Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary Syndrome

Identificadores
URI: https://hdl.handle.net/10481/110769
Exportar
RISMendeleyBibtex
Estadísticas
Ver Estadísticas de uso
Metadatos
Mostrar el registro completo del ítem
Autor
Herrera, Alberto; Fredholm, Simon; Cheng, Anthony; Mimitou, Eleni; Seffens, Angelina; Bar-Natan, Michal; Sun, Amy; Latkowski, Jo-Ann; Willerslew-Olsen, Andreas; Buus, Terkild; Gluud, Maria; Krejsgaard, Thorbjon; Torres Rusillo, Sara; Menne Bonefeld, Charlotte; Woetmann, Anders; Geisler, Carsten; Geskin, Larisa J.; Ouyang, Zhengqing; Smibert, Peter; Odum, Niels; Koralov, Sergei B.
Editorial
Elsevier
Materia
CTCL
 
SATB1
 
Sezary Syndrome
 
Fecha
2020-03
Referencia bibliográfica
A Herrera et al. Low SATB1 Expression in Sezary Syndrome. Journal of Investigative Dermatology (2020), Volume 140. DOI: 10.1016/j.jid.2019.07.714
Patrocinador
LEO Foundation; Novo Nordisk Research Foundation (NNF14OC0012345); Danish Cancer Society (Kræftens Bekæmpelse); Fight Cancer Program (Knæk Cancer); Lundbeck Foundation; National Institutes of Health R01 grant (HL-125816); Judith and Stewart Colton Center for Autoimmunity Pilot; Drs. Martin and Dorothy Spatz Foundation; Howard Hughes Medical Institute Medical Scholar Fellowship
Colecciones